Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...
TipRanks on MSN
Eli Lilly’s Mounjaro recommended for extended use by EMA
The European Medicines Agency’s, EMA, committee recommended a change to extend the use of Eli Lilly’s (LLY) Mounjaro for the treatment of type 2 ...
The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...
PICKING up her phone, Oonagh Van der Berg goes to read a WhatsApp message – but the 45-year-old, from Belfast, can’t focus.
Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...
Novo Nordisk finds itself navigating significant operational and market headwinds. The company is intensely focused on maintaining its leadership in the obes ...
Goldman Sachs raised the firm’s price target on Eli Lilly (LLY) to $1,145 from $951 and keeps a Buy rating on the shares. Published first on ...
9hon MSN
Ozempic Launches In India: Doctors Reveal Weight Loss Benefits, Risks, And Who Should Use It
Ozempic has officially arrived in India at a comparatively affordable price, sparking buzz among diabetes and weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback